KURA Stock Analysis: Buy, Sell, or Hold?
KURA - Kura Oncology, Inc.
$11.34
0.43 (3.94%)
▲
5d:
-5.42%
30d:
+27.99%
90d:
+30.05%
HOLD
LOW Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 06, 2026
22d
Smart Money Accumulation
None View Scanner →
Strength: 6.6/10
Get Alerted When KURA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: KURA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: KURA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: KURA is currently trading at $11.34, which is considered slightly high relative to its 30-day fair value range of $9.24 to $11.41.
Technical Outlook: Technically, KURA is in a strong uptrend. Immediate support is located at $10.65, while resistance sits at $12.22. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: KURA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $31.17 (+185.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, KURA is in a strong uptrend. Immediate support is located at $10.65, while resistance sits at $12.22. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: KURA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $31.17 (+185.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$9.24 -
$11.41
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
84.2%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.9%)
- BULLISH: Trading 185.7% below Wall St target ($31.17)
- CAUTION: Recommendation downgraded due to -5.4% 5-day decline
Trading Range Analysis
30-Day Trading Range
$9.24 -
$11.41
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$10.65
Resistance Level
$12.22
Current Trend
Strong Uptrend
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.20
Wall Street Target
$31.17
(+185.7%)
Revenue Growth (YoY)
29.5%
Share & Embed Analysis
Last updated: July 14, 2026 1:43 PM ET
Data refreshes hourly during market hours. Next update: 2:43 PM
Data refreshes hourly during market hours. Next update: 2:43 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KURA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Francis Burrows
SELL
1311 shares
2026-01-27
Kathleen Ford
SELL
1813 shares
2026-01-27
Mollie Leoni
SELL
8180 shares
2026-01-27
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 66 BUY |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 64 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 45 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$277 | 51 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
